Revenue: Reported Q1 2024 revenue of $19.53 million, significantly surpassing the estimated $6.03 million.
Net Loss: Q1 2024 net loss narrowed to $26.56 million from $39.06 million in Q1 2023, significantly better than the estimated net loss of $55.05 million.
Earnings Per Share: Loss per share improved to $0.62 in Q1 2024 from $1.30 in Q1 2023, worse than the estimated loss per share of $1.24.
Cash Position: Cash and cash equivalents stood at $456.99 million as of March 31, 2024, providing a financial runway into 2026.
Research and Development Expenses: Increased to $34.86 million in Q1 2024 from $32.21 million in Q1 2023, reflecting ongoing investment in the R&D pipeline.
General and Administrative Expenses: Rose to $16.38 million in Q1 2024 from $14.49 million in the previous year, indicating growth in operational scale.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.